[Chronic ulcerative stomatitis (CUS): a new disease entity with specific immunological marker (SES-ANA)].
A review of recently described cases with oral chronic erosive or ulcerative lesions associated with stratified epithelium specific antinuclear antibodies (SES-ANA) is presented. The lesions are refractory to local and systemic corticosteroids but may be responsive to hydroxychloroquine.
Chorzelski
T P
TP
Kliniki Dermatologicznej AM w Warszawie.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000974:Antibodies, Antinuclear / Q000276:immunology*; D000918:Antibody Specificity; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000276:immunology; D015415:Biomarkers; D002908:Chronic Disease; D005260:Female; D005455:Fluorescent Antibody Technique; D005892:Gingivitis, Necrotizing Ulcerative / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008875:Middle Aged
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D015415:Biomarkers; D006886:Hydroxychloroquine
Chronic ulcerative stomatitis (CUS): nowa jednostka chorobowa ze swoistym markerem immunologicznym (SES-ANA).